Chimeric CTLA4-CD28-CD3z T Cells Potentiate Antitumor Activity Against CD80/CD86–Positive B Cell Malignancies

The adoptive transfer of chimeric antigen receptor T (CAR T) cells have been recognized as a promising therapeutic strategy for the treatment of hematological malignancies; however, clinical success using CAR T cells for the treatment of solid tumors are still limited since the T-cell function is in...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Immunol
Main Authors: Lin, Shouheng, Cheng, Lin, Ye, Wei, Li, Shanglin, Zheng, Diwei, Qin, Le, Wu, Qiting, Long, Youguo, Lin, Simiao, Wang, Suna, Huang, Guohua, Li, Peng, Yao, Yao, Sun, Xiaofang
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2021
Assuntos:
Immunology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8050336/
https://ncbi.nlm.nih.gov/pubmed/33868277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.642528
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares